Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?

• Andrea Botticelli,

  Affiliation Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy

  ⨯
• Marina Borro,

  Affiliation Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), “Sapienza” University of Rome, Rome, Italy

  ⨯
• Concetta Elisa Onesti ,

  * E-mail: elisaonesti@gmail.com

  Affiliation Medical Oncology Unit, Sant’Andrea Hospital, Rome, Italy

  ⨯
• Lidia Strigari,

  Affiliation Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy

  ⨯
• Giovanna Gentile,

  Affiliation Istituto Dermopatico dell’Immacolata-IRCCS, Rome, Italy

  ⨯
• Bruna Cerbelli,

  Affiliation Department of Radiological Oncological and Pathological Sciences, “Sapienza” University of Rome, Rome, Italy

  ⨯
• Adriana Romiti,

  Affiliation Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy

  ⨯
• Mario Occhipinti,

  Affiliation Medical Oncology Unit, Sant’Andrea Hospital, Rome, Italy

  ⨯
• Claudia Sebastiani,

  Affiliation Istituto Dermopatico dell’Immacolata-IRCCS, Rome, Italy

  ⨯
• Luana Lionetto,

  Affiliation Istituto Dermopatico dell’Immacolata-IRCCS, Rome, Italy

  ⨯
• Luca Marchetti,

  Affiliation Department of Medical Oncology, Policlinico Umberto I, Rome, Italy

  ⨯
• Maurizio Simmaco,

  Affiliation Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), “Sapienza” University of Rome, Rome, Italy

  ⨯
• Paolo Marchetti,

  Affiliations Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy, Medical Oncology Unit, Sant’Andrea Hospital, Rome, Italy, Istituto Dermopatico dell’Immacolata-IRCCS, Rome, Italy

  ⨯
• Federica Mazzuca

  Affiliations Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy, Medical Oncology Unit, Sant’Andrea Hospital, Rome, Italy

  ⨯